id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_bf6do22xsbddjnaixc6n5zhv5y	Bilal Anouti	Prognostic variables associated with improved outcomes in patients with stage III NSCLC treated with chemoradiation followed by consolidation Pembrolizumab: a subset analysis of a phase II study from the Hoosier Cancer Research Network LUN 14-179	2019	14	.pdf	application/pdf	4365	621	65	Prognostic variables associated with improved outcomes in patients with stage III NSCLC treated with chemoradiation followed by consolidation Pembrolizumab: a subset analysis of a phase II study from the Hoosier Cancer Research Network LUN 14-179 Prognostic variables associated with improved outcomes in patients patients with stage III NSCLC treated with chemoradiation followed by consolidation Pembrolizumab: A subset concurrent chemoradiation for the treatment of patients with stage III NSCLC. study, patients with stage III NSCLC were treated with a variety of chemotherapy regimens pembrolizumab after chemoradiation in patients with stage III NSCLC. Prognostic variables associated with improved outcomes in patients with stage III improvements in TMDD, PFS, and OS in patients with stage III NSCLC treated with Prognostic variables associated with better or worse outcomes for patients with stage III with outcomes in patients with stage III NSCLC treated with chemoradiation followed by consolidation pembrolizumab in patients with unresectable stage III non-small cell lung cancer: Hoosier 	./cache/work_bf6do22xsbddjnaixc6n5zhv5y.pdf	./txt/work_bf6do22xsbddjnaixc6n5zhv5y.txt